Biographies: College Chairs

Executive Chair

Paul Kubes, PhD
Professor
University of Calgary

Dr. Paul Kubes is a Professor at the University of Calgary Faculty of Medicine and Founding Director of the Snyder Institute for Chronic Diseases. He also holds a Canada Research Chair in Leukocyte Recruitment in inflammatory disease.

Dr. Kubes has received numerous awards including the CIHR Investigator of the Year in 2011 for his basic science work on how the brain affects immunity. He has also received the Alberta Science and Technology Award and the Henry Friesen Award. Dr. Kubes has published basic science work in Cell, Science and the Nature journals and also has publications in both clinical journals including Lancet and more translational journals (JCI).

Dr. Kubes has extensive review experience with CIHR having been part of numerous committees including the Immunology panel, Cardiovascular A and B panel, the CIHR scholar panel and the Banting postdoctoral panel. He also served as a member of CIHR Governing Council. In addition, he has reviewed for NIH and he co-chairs the Gairdner Research Committee.

Chairs

Eric Brown, PhD
Professor
McMaster University

Dr. Eric Brown is a Professor in the Department of Biochemistry and Biomedical Sciences and member of the DeGroote Institute for Infectious Disease Research at McMaster University.

Dr. Brown holds a Canada Research Chair in Microbial Chemical Biology and has a long-standing research interest in the complex biology that underlies bacterial survival strategies. He and his research team ultimately aim to subvert these systems in drug resistant superbugs and contribute fresh directions for new antibiotics. He has been the recipient of a number of awards for this work including the Canadian Society of Microbiologists Murray Award for career achievement and as a Fellow of the American Academy of Microbiology.

Dr. Brown has served extensively on Canadian Institutes of Health Research peer review committees and on a wide variety of advisory boards including a term as President of the Canadian Society for Molecular Biosciences, member of the Medical Review Panel of the Gairdner Foundation, and member of the Institute of Infection and Immunity of the Canadian Institutes of Health Research.


Max S. Cynader, C.M., O.B.C., PhD, F.R.S.C.
Founding Director, Djavad Mowafaghian Centre for Brain Health
University of British Columbia

Dr. Max Cynader is the Founding Director of the Brain Research Centre, and the Djavad Mowafaghian Centre for Brain Health at Vancouver Coastal Health and The University of British Columbia (UBC). He is a Member of the Order of Canada (CM), Member of the Order of British Columbia (OBC), Fellow of The Royal Society of Canada (FRSC), Fellow of The Canadian Academy for Health Sciences (FCAHS), and a Principal Investigator in Canada’s Network of Excellence in Stroke.

Dr. Cynader’s research has focused on the nature of the processing performed by the cerebral cortex, especially the sensory cortices dealing with vision and audition, and on the neural and molecular mechanisms underlying the development and adaptability of the cortex. He has worked to understand the mechanisms by which early use or misuse of the brain affects its functioning for the rest of the organism’s life. More recently, Dr. Cynader has co-founded two new start-ups: a biotech called Primary Peptides and a Brain Health company called Synaptitude.

Dr. Cynader has considerable review experience with CIHR as a member and grant review panel chair and with several international funding organizations such as the International Human Frontiers of Science Program and the National Institutes of Health.


Jayne Danska, PhD
Senior Scientist
Hospital for Sick Children

Dr. Jayne Danska is the Anne and Max Tanenbaum Chair in Molecular medicine and a Senior Scientist at the Hospital for Sick Children as well as a Professor in the Faculty of Medicine, University of Toronto.

Dr. Danska’s research is focused on the causes of autoimmune disease, mechanisms of lymphocytic leukemia, and innate immune surveillance of cancer cells. Her work spans mechanistic discovery in animal models to identification of biomarkers and therapeutic targets in human disease, including clinical development of a novel immune checkpoint biologic that is now in phase 1 trials for hematologic malignancies. Her group has identified genetic and environmental causes of Type 1 diabetes, and shown that the gut microbiome alters sex hormones, regulates immune responses and can be modified in early life to block Type 1 diabetes. The underlying causes of the sex bias in many autoimmune diseases are poorly understood. Dr. Danska’s work has defined a link between the gut microbiome and sex hormone-mediated differences in immune mediated disease. She is engaged in international prospective human studies to define early life risk factors for immune-mediated disease in infants and children, and the effect of migration on risk for immune-mediated disease in new Canadians.

Dr. Danska’s review experience includes serving as a panel member, Scientific Officer and Chair at CIHR for many years. She has also served as panel member and Chair for the Canadian Cancer Society, Canadian Diabetes Association, and multiple institutes within the U.S. National Institutes of Health.


Sherry L. Dupuis, PhD
Professor
University of Waterloo

Dr. Sherry Dupuis is a Professor in Recreation and Leisure Studies and the former Director of the Murray Alzheimer Research and Education Program at the University of Waterloo. She also co-leads the Partnerships in Dementia Care Alliance, a national research initiative focused on culture change in dementia and long-term care.

Dr. Dupuis has been a pioneer in the active engagement of persons living with dementia and their family care partners as co-researchers in research and knowledge translation processes. Committed to issues of social justice and the transformation of dementia and long-term care, Dr. Dupuis uses critical participatory action research and innovative arts-based methodologies as a means of promoting personal transformation and social change. Her most recent example is “Cracked: New Light on Dementia”, a research-based theatre production that casts a critical light on society’s one-dimensional view of dementia as an unmitigated tragedy and exposes dehumanizing policies and practices in dementia care.

Dr. Dupuis has extensive experience as an external reviewer for both tri-council and other provincial and national granting programs including SSHRC, CIHR, Alzheimer Society of Canada, Manitoba Health Research Council, UHN Collaborative Research Program, Michael Smith Foundation for Health Research, and the TVN Catalyst Grant Program.


Richard Glazier, MD, MPH, FCFP
Senior Scientist and Program Lead, Primary Care and Population Health
Institute for Clinical Evaluative Sciences

Dr. Richard Glazier is a Family Physician and Senior Scientist and Program Lead of Primary Care and Population Health at the Institute for Clinical Evaluative Sciences (ICES). He is a staff family physician at St. Michael’s Hospital in Toronto and a Scientist in its Centre for Research on Inner City Health. At the University of Toronto, Dr. Glazier is a Professor in the Department of Family and Community Medicine, the Dalla Lana School of Public Health, and the Institute for Health Policy, Management and Evaluation. He is an international leader in primary care research and he recently served as President of the North American Primary Care Research Group (NAPCRG).

Dr. Glazier’s research focuses on evaluating health system transformation, primary care health services delivery models, health of disadvantaged populations, management of chronic conditions, and population-based and geographic methods for improving equity in health. He has held numerous CIHR grants as PI going back to the founding of CIHR and he participates in a number of CIHR-funded Community-Based Primary Healthcare teams.

Dr. Glazier served until very recently on the Institute Advisory Board for the CIHR Institute of Health Services and Policy Research and in the past served as a reviewer and as Chair for the CIHR peer-review committee on Health Services Evaluation & Interventions Research. He currently serves as a Virtual Chair for the CIHR Project Scheme.


Philippe Gros, PhD
Vice-Dean, Faculty of Medicine
McGill University

Dr. Philippe Gros obtained his PhD in Experimental Medicine from McGill University and following post-doctoral training at Massachusetts General Hospital and MIT, joined the Department of Biochemistry at McGill in 1985, where he has been a full Professor since 1994. He is a member of the Center for Tuberculosis, the Goodman Cancer Research Center, is the founder of the Center for Complex Traits and is the Vice-Dean of the Faculty of Medicine at McGill.

Dr. Gros’ main area of investigation concerns the genetic analysis of susceptibility to infections, and pathological inflammation. Dr. Gros has been an International Scholar of the Howard Hughes Medical Institute, a Distinguished Scientist of the Canadian Institutes of Health Research and is a James McGill Professor. He has received the Wilder Penfield Prize for Health Sciences (Prix du Quebec), the Canada Council Killam Prize for Health Research, and is a fellow of the Royal Society of Canada. Dr. Gros is experienced in the biotechnology sector, and has co-founded two biotechnology companies.

Dr. Gros has extensive experience in peer review and evaluation with the Burroughs Wellcome Fund, the Bill and Melinda Gates Foundation, the National Institutes of Health (USA) and the Canadian Institutes of Health Research, where he was a member of Governing Council for four years.


Peter Jones, PhD
Director, Richardson Centre for Functional Foods and Nutraceuticals
University of Manitoba

Dr. Jones is currently the Canada Research Chair in Functional Foods and Nutrition, and he joined the University of Manitoba on November 1, 2005, as Director of the Richardson Centre for Functional Foods and Nutraceuticals. Dr. Jones is also founder and president of Nutritional Foundations for Health Inc., based in Montreal.

Dr. Jones has spent nearly three decades exploring the medicinal benefits of food, helping to shape the nutrition landscape in Canada and beyond our borders. Dr. Jones’s ground-breaking research showed that essential fatty acids, found in crops like flax and canola, can reduce our risk of cardiovascular disease. He also showed that plant sterols, naturally occurring in foods such as grains and vegetables, can lower cholesterol. His research was so robust that in 2010 Health Canada gave food companies the right to share this claim on their labeling.

Dr. Jones serves on national grant review committees including Canadian Institutes of Health Research (CIHR) and Heart and Stroke as well as on editorial boards for Journals, including the American Journal of Clinical Nutrition, Lipids and Nutrition Reviews. He also served as member of the Institute Advisory Board for the CIHR Institute of Nutrition, Metabolism and Diabetes.


Josée Lavoie, PhD
Professor
University of Manitoba

Dr. Josée Lavoie is the Director of the Manitoba First Nations Centre for Aboriginal Health Research (MFN CAHR) and Professor in the Faculty of Health Sciences at the University of Manitoba. She maintains a university appointment at the University of Northern British Columbia. She has worked in First Nation and Inuit Primary Health Care systems since 1989.

Dr. Lavoie has research expertise in health policy, financing, and contracting in health. She has been involved in the development of optimal models of contracting in health in indigenous environments in Canada, Australia, New Zealand and in circumpolar countries.

Dr. Lavoie has served as a reviewer for several national and international organizations including CIHR, the Michael Smith Foundation for Health Research, the International Development Research Centre and Australia Primary Health Research Institute.


Dawn Martin Hill, PhD
Associate Professor
McMaster University

Dr. Dawn Martin Hill (Mohawk, Six Nations) holds a PhD in Cultural Anthropology and is one of the original founders of the Indigenous Studies Program at McMaster University. She is the inaugural Paul R. McPherson Indigenous Studies Chair.

Dr. Martin Hill’s research is grounded in the principle that solution-based research in the area of Indigenous health must occur alongside building capacity for community collaborations. She has embodied this principle through her numerous community commitments: including serving as Chair of the Indigenous Elders and Youth Council to promote the protection and preservation of Indigenous Knowledge systems; serving as an expert witness on traditional medicines; and supporting reconciliation efforts to improve health services delivery to FN through the “Harmonization of Traditional Medicine” in partnership with Six Nations Health Services. While working with communities, Dr. Martin Hill has led numerous grants funded by both SSHRC and CIHR to conduct Indigenous knowledge research focused on Indigenous youth, women, language, ceremonies, traditional medicine and well-being.

Dr. Martin Hill has served on review committees for CIHR and the Social Sciences and Humanities Research Council. She is currently a member of the Editorial Board of Sociology and Anthropology and a reviewer for The International Indigenous Policy Journal. In addition, Dr. Martin-Hill has led important groundwork for Indigenous peer review capacity in her role as the inaugural chair of Aboriginal Health Research Networks (AHRNets) secretariat. Much of this work included identifying and removing epistemological barriers to Indigenous Knowledge health research. She also worked to develop a cohort of potential Indigenous Knowledge peer reviewers for CIHR-IAPH.

She resides on the Grand River, Six Nations. She is a single mother of four with two teenagers at home and a grandmother of eight, her healthy family is considered her greatest achievement to date.


Patrick McGrath OC, PhD, FRSC, FCAHS
VP Research, Innovation and Knowledge Translation
IWK and Nova Scotia Health Authority

Dr. Patrick McGrath is a clinician-scientist in psychology, senior health administrator and social entrepreneur. He is Professor of Science, Pediatrics, Community Health and Epidemiology and Psychiatry at Dalhousie University and Vice President, Research, Innovation and Knowledge Translation at the IWK Health Centre and at the Nova Scotia Health Authority.

Dr. McGrath’s career focus has been to use research to improve clinical care. He created the Translating Research into Care grants which are a partnership amongst clinician scientists, administrators, patients and the QEII Foundation and the IWK Foundation. He helped found BIOTIC, a translational imaging research facility at the health authorities. His own research is on using technology to deliver care and on pain in children. He spun out the not for profit Strongest Families Institute that delivers mental health care to thousands of families across Canada, in Finland and in Vietnam.

Dr. McGrath has received numerous national and international awards for his research, mentoring, leadership and advocacy including being appointed an Officer of the Order of Canada, being elected as fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences. He won the Principal Award of the Manning Foundation for the best innovation in Canada in 2013, the Strongest Families Institute. In 2016 he was honoured with the Legacy of Leadership Award from HealthCareCan.

Dr. McGrath has a longstanding interest in peer review and has served on numerous peer review grant committees, editorial boards and peer evaluation committees and also served as a member of CIHR’s Governing Council.


Barbara Morrongiello, PhD
Professor
University of Guelph

Dr. Barbara Morrongiello is a Professor in Clinical Psychology at the University of Guelph, a registered Psychologist in Ontario, and Director of the Child Development Research Unit.

In addition to receiving numerous research achievement awards, Dr. Morrongiello holds a Canada Research Chair (Tier I) in Child and Youth Injury Prevention and is a Fellow both in the Canadian Academy of Health Sciences and the American Psychological Association.

Dr. Morrongiello has published over 150 peer-refereed articles and has a long history of research innovation and productivity. Her pioneering research applies a developmental framework to study risk factors for injury at different stages throughout childhood, focuses on understanding gender differences in childhood injuries, and has contributed numerous innovative methods and measures to advance the study of risk processes leading to childhood injuries. Based on her findings she has implemented a number of evidence-based intervention programs (e.g., Supervising for Home Safety program, Cool 2 Be Safe playground safety program) that have been shown to reduce children’s risk of injuries. She is committed to working with key stakeholders (e.g., school boards, Public Health Agency of Canada) so effective programs can be broadly disseminated to reduce the burden of childhood injuries in Canada.

Dr. Morrongiello serves on the advisory boards of several scientific journals, and has peer review experience with several organizations including the Ontario Mental Health Foundation, Social Sciences and Humanities Research Council and CIHR where she served as a scientific officer.


Steven Narod, MD, FRCPC, FRSC
Director, Familial Breast Cancer Research Unit
Women’s College Research Institute

Dr. Steven Narod is a Tier I Canada Research Chair in Breast Cancer, a professor in the Dalla Lana School of Public Health and the Department of Medicine at the University of Toronto and a senior scientist at Women’s College Research Institute, where he directs the Familial Breast Cancer Research Unit.

Dr. Narod is a world-leader in the field of breast and ovarian cancer. Over the course of his career, he has profoundly shaped our knowledge of how to assess risk for breast and ovarian cancer and how to reduce mortality among women who have BRCA1 and BRCA2 mutations. He studies various aspects of cancer genetics, including prevention, screening and treatment. Dr. Narod has identified founder mutations in a number of ethnic populations. His database of over 15,000 women with mutations from 30 countries supports numerous international collaborations. With more than 700 peer-reviewed publications and an h-index of 99, Dr. Narod is one of the most highly cited cancer researchers in the world. In 2012, Dr. Narod was elected as a Fellow of the Royal Society of Canada, and in 2016 he received the prestigious Killam Prize for Health Sciences.

Dr. Narod has served as a reviewer for many national and international organizations including CIHR, the Italian Association for Cancer Research, the National Science Centre in Poland and the Health Research Board in Ireland.


Morag Park, PhD, F.R.S.C.
Director, Goodman Cancer Research Centre
Diane and Sal Guerrera Chair in Cancer Genetics
James McGill Professor
McGill University

Dr. Morag Park is a Professor in the Departments of Oncology and Biochemistry and joined McGill in 1989. She is a Fellow of the Royal Society of Canada, James McGill Professor and holds the Diane and Sal Guerrera Chair in Cancer Genetics at McGill University. She was the Director of the Molecular Oncology Group at the McGill University Hospital Centre (2006‑8), Scientific Director of the CIHR Institute of Cancer Research (2008‑13), co-chair of the Canadian Cancer Research Alliance (2008‑2010) and is now Director of the Goodman Cancer Research Centre (2013 - present).

Dr. Park is a research leader in the field of receptor tyrosine kinases (RTK) and mechanisms of oncogenic activation of RTKs in human cancers. She has recently developed leadership in the breast cancer microenvironment. She is the elected chair of the Tumour Microenvironment Network of the American Association for Cancer Research (2015‑2017). She is a recent recipient of a Canadian Cancer Research Alliance Award (2015) for Exceptional Leadership in Cancer Research. She has more than 180 publications.

Dr. Park has served as a peer reviewer for many organizations including CIHR, Cancer Research UK and Fonds de recherche Santé Québec.


Louise Potvin, PhD, FCAHS
Professor
Université de Montréal

Dr. Potvin is Professor of Health Promotion at the Department of Social and Preventive Medicine, School of Public Health, Université de Montréal.  She is the Scientific Director of the Léa-Roback Research Centre on Health Inequalities.  She holds the Canada Research Chair in Community Approaches and Health Inequalities. She is the Editor in Chief of the Canadian Journal of Public health.  She is a Director of the Canadian Academy of Health Sciences, a member of the International Scientific Advisory Council of the Institut national du Cancer (France), and the Vice-President for Scientific Affairs of the International Union for Health Promotion and Education.

For the past three decades Dr. Potvin has conducted research in Canada and abroad, on the processes and outcomes of community-based health promotion and chronic disease prevention interventions.  Her work was pivotal for the recognition of the necessity for a plurality of methods for evaluating non clinical community prevention.  She has been a leading figure in the development of population health intervention research, a domain of scientific research that seeks to develop relevant evidence about public health intervention.  Her work contributed to showing how public health interventions can reduce health inequalities through increasing local access to high quality resources.

Dr. Potvin has extensive experience in peer-review committees. She has chaired numerous CIHR-IPPH strategic initiative peer-review committees. She served as a representative of pillar 4 on several interdisciplinary committees (Banting post-doctoral fellowship; MRC Career Award, CIHR Foundation live pilot stage 3).  More recently, she supported the establishment of international peer-review committees in population health intervention research in France and in Germany. Until recently she was a member of IPPH Advisory Board. 


Jane Rylett, PhD
Professor
Western University

Dr. Jane Rylett is a Distinguished University Professor and Chair of the Department of Physiology and Pharmacology in the Schulich School of Medicine & Dentistry at Western University, and a Scientist in the Molecular Medicine Group at Robarts Research Institute. Following a PhD in Pharmacology, she trained at University College London, England and Max-Planck-Institute for Biophysical Chemistry, Germany.

Dr. Rylett is a cellular and molecular neurobiologist and Alzheimer’s disease researcher recognized internationally for contributions in cholinergic neurobiology. Her laboratory addresses the impact of aging and disease on neurochemical communication. She is leader of the Canadian Consortium on Neurodegeneration in Aging (CCNA) Theme 1 – Prevention, and member of the Biology Working Group of the Canadian Longitudinal Study on Aging (CLSA). She is an elected fellow of the Canadian Academy of Health Sciences.

Dr. Rylett has a long history of experience on peer-review panels for granting councils and foundations and has contributed to research policy groups, currently serving on the Alzheimer Society of Canada Research Policy Committee. She was appointed as Chair of the CIHR Institute of Aging Institute Advisory Board (IAB), and has served on Boards of Directors of the Alzheimer Societies of Canada and Ontario and taskforces for international endeavours for Alzheimer disease research.


David Thomas, PhD, FRSC
Professor
McGill University

Dr. David Thomas was trained in genetics at University College London, and has held a variety of posts in his research career. He is currently a Professor in the Biochemistry and Human Genetics Departments, McGill University and is co-director of the Cystic Fibrosis Translational Research center (CFTRc), He holds the tier 1 Canada Research Chair in Molecular Genetics.

Dr. Thomas has made original research contributions in mitochondrial genetics, protein processing, protein folding in the ER, G protein signaling, and defining MAP kinase cascades. Since his move from the National Research Council of Canada (NRC) to McGill in 2001 he has developed a research programme on the mechanism of ER quality control and its impact on protein trafficking diseases such as cystic fibrosis, using a variety of high and low throughput technologies. He has served and played a leadership role on planning committees at the NRC, Medical Research Council and McGill.

Throughout his career, Dr. Thomas has served as a peer reviewer for many international and national organizations. He currently serves on grants review panels for several agencies, including, CIHR and the Ontario Research Foundation.

Date modified: